PLACEHOLDER: Free shipping over $XX — confirm threshold

Topical cosmetics and devices only — not for injection

Cellular Sequence

Peptide Encyclopaedia

For research purposes onlyInvestigationalNot approved for human use

Mazdutide

Research / investigational listing only. This compound is not available for consumer purchase from Cellular Sequence and must not be confused with shop products.

Research / investigational compoundThis compound does not have an established approved therapeutic dosing schedule. Doses below describe those reported in published scientific research and should not be interpreted as a treatment recommendation.

At-a-glance profile

Classification
GLP-1/glucagon dual agonist (investigational)
Approval status
Investigational · Not approved for human use
Research status
Investigational / reference listing.
Molecular formula
Insufficient reliable evidence identified.
Molecular weight
Insufficient reliable evidence identified.
Sequence
Oxyntomodulin-inspired dual agonist in clinical development.
Primary biological target
Insufficient reliable evidence identified.
Half-life
Insufficient reliable evidence identified.
Routes investigated
Insufficient reliable evidence identified.
Human evidence level
C — Limited or early human evidence

What is it?

Investigational metabolic peptide. Not sold.

Mechanism of action

GLP-1 and glucagon receptor activity.

Experimental.

What is it being studied for?

  • Obesity, diabetes (development)

Investigational findings are not proven clinical benefits unless an authority has labelled that indication.

Evidence level

Overall human evidence grade: C · Limited or early human evidence

Human research

Development-stage human data.

Preclinical research

Animal, cell and in-vitro findings are listed separately from human effects.

Dual-agonist models.

Doses reported in published research

This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.

Doses reported in human studies

Insufficient reliable evidence identified.

Preclinical / animal study dosing

Insufficient reliable evidence identified.

Pharmacokinetics

Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.

Safety

GI and metabolic class effects.

Unknowns. Absence of a published harm signal is not evidence of safety.

Contraindications. Not for unapproved use.

Regulatory status

Investigational / regionally developing.

Not sold. Educational.

Citations

  1. [1] Encyclopaedia note

    Encyclopaedia note

For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.

Last reviewed 2026-09-13. Research areas: Metabolic · Compare peptides